Artificial Insemination Market Analysis By Type (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination), By End-use, By Source Type, And Segment Forecasts, 2018 - 2025

  • ID: 4582089
  • Report
  • 80 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Genea Limited
  • Hi-Tech Solutions
  • Irvine Scientific
  • Kitazato
  • Pride Angel
  • Rocket Medical PLC
  • MORE
The global artificial insemination market is expected to reach USD 2.63 billion by 2025. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment for infertility. According to WHO, around 10% of women in the world are struggling to get pregnant. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in infertility around the world.

The exact estimation of infertility statistics is challenging, however, WHO monitors its prevalence across the world. At present, 46% of the global population lives in countries having low levels of fertility. According to United Nations, the global rate of fertility is expected to decline to 2.4 by 2030 and 2.2 by 2050. In developing or underdeveloped nations, medical consultation regarding infertility and childlessness was not easily accessible. Hence, there was lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF.

Further Key Findings From the Report Suggest:
  • Artificial insemination is a first-line infertility treatment as it is minimally invasive and less expensive as compared to IVF
  • It is preferred mostly by single women who wish to conceive and same-sex partners with the help of fresh or frozen donor sperm samples. In some countries, lesbian couples are provided insurance coverage for these procedures
  • Intrauterine Insemination (IUI) held majority of the market share in 2017 and is likely to be the fastest-growing segment over the forecast period, as it is the most common and noninvasive procedure.
  • Fertility clinics held majority of the market share in 2017 as the number of medical facilities offering infertility treatments has been increasing over the past decade
  • Fertility clinics provide medical consultation regarding the detection of ovulation to perform the procedure for insemination. Sperm washing is also performed in the clinics to achieve optimum results
  • Artificial insemination with partner’s or (AIH) sample held the majority of the source type segment share
  • Europe held majority of the market share in 2017 due to the presence of the largest number of patients and easily accessible treatment options
  • On the other hand, Asia Pacific is expected to be the fastest-growing regional market due to increase in awareness regarding artificial or donor insemination in the region
  • Some of the key players in this market include Irvine Scientific; Rinovum Women’s Health, LLC; TenderNeeds Fertility; Conceivex, Inc.; Hi-Tech Solutions; among others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Genea Limited
  • Hi-Tech Solutions
  • Irvine Scientific
  • Kitazato
  • Pride Angel
  • Rocket Medical PLC
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis

Chapter 3 Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Constant rise in infertility rate
3.1.1.2 Growing awareness and social acceptance of assisted reproductive technologies
3.1.1.3 Single women and same-sex couples prefer artificial insemination
3.1.2 Market restraints analysis
3.1.2.1 Unsupportive government regulations in certain areas
3.2 Penetration & Growth Prospect Mapping
3.3 Artificial Insemination - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.4 Artificial Insemination - Industry Analysis - Porter’s

Chapter 4 Artificial Insemination: Type Estimates & Trend Analysis
4.1 Artificial Insemination: Type Analysis
4.2 Intrauterine Insemination
4.2.1 Intrauterine insemination market, 2014 - 2025 (USD Million)
4.3 Intracervical Insemination
4.3.1 Intracervical insemination market, 2014 - 2025 (USD Million)
4.4 Intravaginal Insemination
4.4.1 Intravaginal insemination market, 2014 - 2025 (USD Million)
4.5 Intratubal Insemination
4.5.1 Intratubal insemination market, 2014 - 2025 (USD Million)

Chapter 5 Artificial Insemination: End-use Estimates & Trend Analysis
5.1 Artificial Insemination: End-use Analysis
5.2 Fertility Clinics & Others
5.2.1 Fertility clinics & others artificial insemination market, 2014 - 2025 (USD Million)
5.3 Home
5.3.1 Home market, 2014 - 2025 (USD Million)

Chapter 6 Artificial Insemination: Source Type Estimates & Trend Analysis
6.1 Artificial Insemination: Source Type Analysis
6.2 AIH - Husband
6.2.1 AIH - husband artificial insemination market, 2014 - 2025 (USD Million)
6.3 AIH - Donor
6.3.1 AIH - donor market, 2014 - 2025 (USD Million)

Chapter 7 Artificial Insemination: Regional Estimates & Trend Analysis
7.1 Artificial Insemination Market: Regional Movement analysis
7.2 North America
7.2.1 North America artificial insemination market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. artificial insemination market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada artificial insemination market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe artificial insemination market, 2014 - 2025 (USD Million)
7.3.2 UK
7.3.2.1 UK artificial insemination market, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Germany artificial insemination market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific artificial insemination market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan artificial insemination market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China artificial insemination market, 2014 - 2025 (USD Million)
7.4.4 India
7.4.4.1 India artificial insemination market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America artificial insemination market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil artificial insemination market, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico artificial insemination market, 2014 - 2025 (USD Million)
7.6 Middle East and Africa (MEA)
7.6.1 Middle East and Africa artificial insemination market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa artificial insemination market, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Vitrolife AB
8.2.1.1 Company overview
8.2.1.2 Product benchmarking
8.2.2 Genea Limited
8.2.2.1 Company overview
8.2.2.2 Product benchmarking
8.2.3 Rinovum Women’s Health LLC
8.2.3.1 Company overview
8.2.3.2 Product benchmarking
8.2.3.3 Strategic initiatives
8.2.4 Pride Angel
8.2.4.1 Company overview
8.2.4.2 Product benchmarking
8.2.5 Hi-Tech Solutions
8.2.5.1 Company overview
8.2.5.2 Product benchmarking
8.2.6 Irvine Scientific
8.2.6.1 Company overview
8.2.6.2 Product benchmarking
8.2.6.3 Strategic initiatives
8.2.7 Kitazato
8.2.7.1 Company overview
8.2.7.2 Product benchmarking
8.2.8 Rocket Medical PLC
8.2.8.1 Company overview
8.2.8.2 Product benchmarking

List of Tables
Table 1 Occurrence of infertility among couples
Table 2 Fertility affecting factors
Table 3 IUI success rate
Table 4 North America artificial insemination market, by country, 2014 - 2025 (USD Million)
Table 5 North America artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 6 North America artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 7 U.S. artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 8 U.S. artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 9 U.S. artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 10 Canada artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 11 Canada artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 12 Canada artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 13 Europe artificial insemination market, by country, 2014 - 2025 (USD Million)
Table 14 Europe artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 15 Europe artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 16 Europe artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 17 UK artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 18 UK artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 19 UK artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 20 Germany artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 21 Germany artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 22 Germany artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 23 Asia Pacific artificial insemination market, by country, 2014 - 2025 (USD Million)
Table 24 Asia Pacific artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 25 Asia Pacific artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 26 Asia Pacific artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 27 Japan artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 28 Japan artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 29 Japan artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 30 China artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 31 China artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 32 China artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 33 India artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 34 India artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 35 India artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 36 Latin America artificial insemination market, by country, 2014 - 2025 (USD Million)
Table 37 Latin America artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 38 Latin America artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 39 Latin America artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 40 Brazil artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 41 Brazil artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 42 Brazil artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 43 Mexico artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 44 Mexico artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 45 Mexico artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 46 Middle East and Africa artificial insemination market, by country, 2014 - 2025 (USD Million)
Table 47 Middle East and Africa artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 48 Middle East and Africa artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 49 Middle East and Africa artificial insemination market, by source type, 2014 - 2025 (USD Million)
Table 50 South Africa artificial insemination market, by type, 2014 - 2025 (USD Million)
Table 51 South Africa artificial insemination market, by end use, 2014 - 2025 (USD Million)
Table 52 South Africa artificial insemination market, by source type, 2014 - 2025 (USD Million)

List of Figures
FIG. 1 Market summary 2016, (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraints relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping, 2016
FIG. 13 SWOT analysis, by factor (political & legal, economic, and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Artificial insemination market, type outlook: Key takeaways
FIG. 16 Artificial insemination: Type movement analysis
FIG. 17 Intrauterine insemination market, 2014 - 2025 (USD Million)
FIG. 18 Intracervical insemination market, 2014 - 2025 (USD Million)
FIG. 19 Intravaginal insemination market, 2014 - 2025 (USD Million)
FIG. 20 Intratubal insemination market, 2014 - 2025 (USD Million)
FIG. 21 Artificial insemination market, end-use outlook: Key takeaways
FIG. 22 Artificial insemination: End-use movement analysis
FIG. 23 Fertility clinics & others artificial insemination market, 2014 - 2025 (USD Million)
FIG. 24 Home market, 2014 - 2025 (USD Million)
FIG. 25 Artificial insemination: source: Type movement analysis
FIG. 26 AIH-Husband artificial insemination market, 2014 - 2025 (USD Million)
FIG. 27 AID-Donor market, 2014 - 2025 (USD Million)
FIG. 28 Regional market place: Key takeaways
FIG. 29 Artificial insemination market: Regional movement analysis
FIG. 30 North America artificial insemination market, 2014 - 2025 (USD Million)
FIG. 31 U.S. artificial insemination market, 2014 - 2025 (USD Million)
FIG. 32 Canada artificial insemination market, 2014 - 2025 (USD Million)
FIG. 33 Europe artificial insemination market, 2014 - 2025 (USD Million)
FIG. 34 UK artificial insemination market, 2014 - 2025 (USD Million)
FIG. 35 Germany artificial insemination market, 2014 - 2025 (USD Million)
FIG. 36 Asia Pacific artificial insemination market, 2014 - 2025 (USD Million)
FIG. 37 Japan artificial insemination market, 2014 - 2025 (USD Million)
FIG. 38 China artificial insemination market, 2014 - 2025 (USD Million)
FIG. 39 India artificial insemination market, 2014 - 2025 (USD Million)
FIG. 40 Latin America artificial insemination market, 2014 - 2025 (USD Million)
FIG. 41 Brazil artificial insemination market, 2014 - 2025 (USD Million)
FIG. 42 Mexico artificial insemination market, 2014 - 2025 (USD Million)
FIG. 43 Middle East and Africa artificial insemination market, 2014 - 2025 (USD Million)
FIG. 44 South Africa artificial insemination market, 2014 - 2025 (USD Million)
FIG. 45 Strategy framework
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Vitrolife AB
  • Genea Limited
  • Rinovum Women’s Health LLC
  • Pride Angel
  • Hi-Tech Solutions
  • Irvine Scientific
  • Kitazato
  • Rocket Medical PLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll